Breaking

healthcare

Guardant Health ordered to pay $245M patent verdict
Research Drops

Guardant Health ordered to pay $245M patent verdict

Guardant Health patent verdict orders the company to pay $245 million for infringing TwinStrand’s DNA sequencing patents, highlighting risks to industry.

Florinda Ashbridge · August 27, 2026
FDA approves new Roche and Lilly Alzheimer’s tests
Drug Watch

FDA approves new Roche and Lilly Alzheimer’s tests

The FDA has officially approved new Alzheimer's tests from Roche and Lilly to assist clinicians in evaluating patients with early signs of…

Zenobia Fairweather · August 26, 2026
Siemens, Philips win ARPA-H grants for stroke robots
Drug Watch

Siemens, Philips win ARPA-H grants for stroke robots

ARPA-H awards up to $175.3M for stroke robots to treat patients without a surgeon, cutting brain restoration time. Learn about the Siemens,…

Zenobia Fairweather · August 22, 2026
FDA Sets Guidelines for Wearable Technology
Wellness Moves

FDA Sets Guidelines for Wearable Technology

FDA sets guidelines for wearable technology to improve clinical trials with digital health measurements.

Florinda Ashbridge · August 22, 2026
Trump picks Overton to head FDA
Daily Health

Trump picks Overton to head FDA

President Trump appoints physician Heidi Overton as the new FDA commissioner to oversee drug approvals and health regulations.

Florinda Ashbridge · August 20, 2026
Users Alarmed After Platform Announces Blocking Policy
Research Drops

Users Alarmed After Platform Announces Blocking Policy

Vitamin D deficiency linked to kidney disease affects bone health, blood pressure, immune function and survival, revealing a critical public health issue.

Zenobia Fairweather · August 3, 2026
Online Service Blocks Users Over Policy Violations
Drug Watch

Online Service Blocks Users Over Policy Violations

Pharmacy oncology is reshaping cancer care as Minnesota leaders tackle operational and financial hurdles to expand outpatient bispecific antibody and CAR T‑cell

Zenobia Fairweather · August 3, 2026
User access restricted after policy breach
Research Drops

User access restricted after policy breach

The FDA approved Simtriyo, a new ADHD medication for adults and children, improving focus and emotional regulation with extended-release benefits.

Florinda Ashbridge · July 28, 2026
User Blocked After Violating Platform Policies
Daily Health

User Blocked After Violating Platform Policies

System alignment is the top hurdle for healthcare leaders, according to the TPG Chief Pharmacy Officer Summit, which found coordination gaps outweigh…

Florinda Ashbridge · July 27, 2026
User Blocked by Online Platform Administrators
Daily Health

User Blocked by Online Platform Administrators

Disrupted HIV/AIDS funding affects 1,700 service sites and 77,000 children, highlighting the need for emergency relief plans like the U.S. President’s Emergency

Zenobia Fairweather · July 27, 2026